INSULINABGABESYSTEME UND -VERFAHREN

European patent · EP3154607 · In force

Register entry

Publication number
EP3154607
Application number
EP15807000
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 8, 2015
Published
Apr 19, 2017
Granted
Dec 20, 2023
Protection ends at the latest
Jun 7, 2035
Next annual fee due
Jun 30, 2027
IPC classes
G16H 20/17 (2018.01)
G16H 40/63 (2018.01)
G16H 40/67 (2018.01)
G16H 50/20 (2018.01)
A61M 5/172 (2006.01)
A61M 5/00 (2006.01)
A61B 5/145 (2006.01)
A61B 5/00 (2006.01)
G16Z 99/00 (2019.01)
Priority
US 201462010385 P 10.06.2014
PCT application
PCT/US2015/034705 08.06.2015
PCT publication
WO2015/191459 17.12.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Oct 30, 2024

    Change

    Published in Swissreg on 30.10.2024

  4. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  5. Dec 20, 2023

    Granted

    Published in Swissreg on 20.12.2023

Parties

Inventor

MAZLISH, Bryan

Milpitas , CA 95035, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.